Gastroenteropancreatic neuroendocrine carcinoma (gep-nec) Clinical Trials
Conditions / Gastroenteropancreatic neuroendocrine carcinoma (gep-nec)
Delta Trials records 1 clinical trial for Gastroenteropancreatic neuroendocrine carcinoma (gep-nec) in its publicly accessible dataset. From the full dataset, 1 actively seeking eligible participants and 0 trials have reached completion. This research is conducted across 11 study locations around the world. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
1
Total Trials
1
Recruiting
0
Completed
0
Other Active
0
Terminated since 2020
11
Study Locations
Browse by location (11 total)
- Portland, United States 1 trialAll trials in Portland, United States
- Chapel Hill, United States 1 trialAll trials in Chapel Hill, United States
- San Antonio, United States 1 trialAll trials in San Antonio, United States
- Denver, United States 1 trialAll trials in Denver, United States
- St. Louis, United States 1 trialAll trials in St. Louis, United States
- St. Louis, United States 1 trialAll trials in St. Louis, United States
- Boston, United States 1 trialAll trials in Boston, United States
- Fairfax, United States 1 trialAll trials in Fairfax, United States
- Oklahoma City, United States 1 trialAll trials in Oklahoma City, United States
- Baltimore, United States 1 trialAll trials in Baltimore, United States
- Duarte, United States 1 trialAll trials in Duarte, United States
- Houston, United States 1 trialAll trials in Houston, United States